Proteome2Pathogen

Solution for microbial identification

Proteome2Pathogen identifies the microbes behind infectious disease in humans with speed and precision. By combining mass spectrometry data with AI-driven classification, it accelerates pathogen detection and supports faster clinical decision-making.

Microbe Detection via Proteome2Pathogen

Developed in collaboration with TNO's scientific team, led by Dr. Armand Paauw, the Proteome2Pathogen application delivers scalable, rapid and accurate microbial identification, bringing same-day biological insight into clinical microbiology.

Proteome2Pathogen features antimicrobial resistance detection.
Equips healthcare practitioners with essential information for making informed clinical decisions.
Enables tailored therapy interventions based on detected resistance.
Translates proteomic data into individualized, clinically actionable care.

How does Proteome2Pathogen work?

Rich microorganism database and validation

The effectiveness of the approach we employ is extensively confirmed by validation studies, which primarily utilize bacteria from simulated blood culture flasks. Our published papers (Berendsen et al., IJMM, 2019; Berendsen et al., Future Microbiol, 2017) provide a thorough documentation of these findings.

Proteome2Pathogen excels in the analysis of proteomes extracted from bacterial colonies cultured on agar plates. This versatility not only ensures reliable analysis but also broadens Proteome2Pathogen's applicability to diverse microbiological situations.

Optimizing speed and precision in microorganism detection

Our application employs a unique two-step workflow, initiating with a genus-level search and proceeding to a species-level identification. This method maximizes the identification speed and accuracy of microorganisms according to their proteome profiles.

The benefits of Proteome2Pathogen

Quick and accurate

Streamlined workflow for rapid and reliable identification of infectious agents.

Versatile

Compatible with multiple types of bacterial samples, including those from simulated blood cultures and agar plates.

Expanding database

Continually updated to include a wider range of microorganisms for even more comprehensive analyses.

Scalability

Designed to accommodate the integration of future functionalities, such as antimicrobial resistance detection.

Same-day pathogen identification

Proteome2Pathogen pairs proteomic analysis with AI-driven classification to improve diagnostic precision and inform treatment decisions. Its adaptive, scalable design integrates with existing clinical microbiology workflows to shorten time to result.